Vivo Capital, LLC Diversified Active

CIK: 0001674712 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 13, 2019

Total Value ($000): $878,828 (100.0% shares, 0.0% debt)

Holdings (5)

— Aclaris Therapeutics, Inc. 68.3%

Value ($000) $600,219 Shares 82,834,668 Est. Cost $7.25 Unrealized —

— Ascendis Pharma A/S 23.7%

Value ($000) $207,939 Shares 2,552,237 Est. Cost $81.47 Unrealized —

— Galmed Pharmaceuticals Ltd 5.5%

Value ($000) $48,250 Shares 9,610,156 Est. Cost $5.02 Unrealized —

— Orchard Therapeutics plc 2.6%

Value ($000) $22,411 Shares 2,805,035 Est. Cost $7.99 Unrealized —

— Soleno Therapeutics, Inc. - Warrant 0.0%

Value ($000) $9 Shares 188,772 Est. Cost $0.05 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Aclaris Therapeutics, Inc.	82,834,668	$600,219	68.3%	$7.25	—	00461U105	000Common
—	Ascendis Pharma A/S	2,552,237	$207,939	23.7%	$81.47	—	04351P101	000000ADR
—	Galmed Pharmaceuticals Ltd	9,610,156	$48,250	5.5%	$5.02	—	M47238106	000000SHS
—	Orchard Therapeutics plc	2,805,035	$22,411	2.6%	$7.99	—	68570P101	000000ADS
—	Soleno Therapeutics, Inc. - Warrant	188,772	$9	0.0%	$0.05	—	834203135	00Warrant